[CAS NO. 193551-21-2]  SB239063

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [193551-21-2]

Store
Catalog
SLK-S7741
Brand
Selleck
CAS
193551-21-2

DESCRIPTION [193551-21-2]

Overview

MDLMFCD03792786
Molecular Weight368.4
Molecular FormulaC20H21FN4O2
SMILESO(C)C=1N=C(C2=C(N=CN2[C@]3(CC[C@H](O)CC3)[H])C4=CC=C(F)C=C4)C=CN1

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.7144 mL13.5722 mL27.1444 mL
5 mM0.5429 mL2.7144 mL5.4289 mL
10 mM0.2714 mL1.3572 mL2.7144 mL
50 mM0.0543 mL0.2714 mL0.5429 mL

Description

SB239063 is a potent and selective inhibitor with of 44 nM, showing no activity against the γ- and δ-kinase isoforms.

Targets

p38α [1]
(Cell-free assay)
p38β [1]
(Cell-free assay)
44 nM44 nM

In vitro

SB 239063 potently inhibits IL-1 and TNF-α production in LPS-stimulated human peripheral blood monocytes with IC50 of 120 and 350 nM, respectively. In oxygen-glucose-deprived hippocampal slice cultures, SB239063 strikingly reduces the levels of the pro-inflammatory cytokine IL-1beta, causes cell death after oxygen-glucose deprivation and significantly diminishes microglia activation. In human corneal endothelial cell, SB 239063 inhibits TGF-β(2) and FGF-2-induced cell migration.

In vivo

In both guinea pigs and mice, SB 239063 (10 mg/kg, p.o.) reduces antigen-induced airway eosinophilia. In air- and ozone-exposed C57/BL6 and MKP-1(-/-) mice, SB239063 inhibits bronchial contraction.


Synonyms

Cyclohexanol, 4-[4-(4-fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl]-, trans-
trans-4-[4-(4-Fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl]cyclohexanol
SB 239063
BRD-K 98143437